ISM5411 is designed to directly regulate the intestinal immune microenvironment so that the drug simultaneously reduces the gut inflammation seen in IBD while also promoting the repair of the ...

The company will develop a pipeline of small molecule inhibitors that target a unique lipid-binding pocket on proteins.

Researchers suggest an application to FDA may be made within the next 12 months, requesting approval to carry out a human clinical trial with the gene therapy.

A new study reveals different types of cancer have unique molecular "fingerprints" which are detectable in early stages of the disease.

A single mutation in the surface protein of the highly pathogenic avian influenza (HPAI) H5N1 influenza virus could allow for easier human transmission.

Research shows that GBM organoids are a powerful, accurate tool for understanding what happens when treating a brain tumor ...

E-Ca coupling is a process that integrates electrical and calcium signaling in brain capillaries to ensure precise blood flow ...

The World Health Organization (WHO) is opening its call for expression of interest (EOI) to join as a Regional Biomanufacturing Training Center under the WHO Biomanufacturing Workforce Training ...

A study in mice offers evidence that inhibiting EZH2 can enhance lymphoma immunogenicity and overcome CAR-T cell therapy resistance.

Cancer immunotherapy strategy equips T cells with molecular GPS that lets them home in on brain tumors and sites of ...

Cathie Wood says a "cure" can generate up to 20x more value than traditional drugs, which appears to explain why two of her firm's funds snapped up shares of the Casgevy co-developer until this past ...

The partners believe the dataset will boost ongoing efforts to use artificial intelligence tools to identify and develop ...